Yayınlar & Eserler

Yayın Ağı
Makaleler 42
Tümü (42)
SCI-E, SSCI, AHCI (41)
SCI-E, SSCI, AHCI, ESCI (42)
ESCI (1)
Scopus (35)
TRDizin (1)

1. Ga-68-labelled PSMA ligand HBED-CC PET/CT imaging in patients with recurrent prostate cancer

AKDEMİR E., TUNCEL M., AKYOL H. F., BİLEN C. Y., Baydar D. E., KARABULUT E., et al.
WORLD JOURNAL OF UROLOGY , cilt.37, sa.5, ss.813-821, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

2. Polyethyleneimine brushes effectively inhibit encrustation on polyurethane ureteral stents both in dynamic bioreactor and in vivo

GULTEKINOGLU M., Kurum B., Karahan S., KART D., SAĞIROĞLU M., Ertas N., et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS , cilt.71, ss.1166-1174, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

3. Therapeutic effects of Mycobacterium phlei cell wall extracts

ORHAN B., BÜBER E., KESKIN M. S., ÇELİKBIÇAK Ö., SALİH B., ALP A., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.42, sa.2, ss.193-199, 2012 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

4. ADT for volume reduction, symptom relief and quality of life improvement in men with prostate cancer: Degarelix versus goserelin plus bicalutamide

Axcrona K., Aaltomaa S., Da Silva C. M., Ozen H., Damber J. E., Tanko L. B., et al.
EUROPEAN UROLOGY SUPPLEMENTS , cilt.11, sa.1, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

5. ROBOTIC RADIOSURGERY IN PROSTATE ADENOCARCINOMA: INITIAL THERAPEUTIC RESULTS AND QUALITY OF LIFE ASSESMENT

Akyol F., Ozyigit G., Sanli Y. T., Cengiz M., Akdogan B., YAZICI M. S., et al.
RADIOTHERAPY AND ONCOLOGY , cilt.96, 2010 (SCI-Expanded, Scopus) identifier

6. Can p53, Ki-67 and bcl-2 predict biochemical failure after radical prostatectomy?

Baseskioglu B., Akdogan B., Baydar D. E., Ozen H.
INDIAN JOURNAL OF UROLOGY , cilt.26, sa.2, ss.206-212, 2010 (ESCI, Scopus) identifier identifier

7. Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis

Eker A., Saka E., Dalmau J., Kurne A., Bilen C., Ozen H., et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , cilt.79, sa.9, ss.1082-1083, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

8. Is intermittent docetaxel chemotherapy reasonable in hormone refractory prostate cancer? A prospective randomised study

Akdogan B., Ozen H., Kirdal Y.
EUROPEAN UROLOGY SUPPLEMENTS , cilt.7, sa.3, ss.231, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

9. A new technique in the treatment of postprostatectomy incontinence: Adjustable male sling

Inci K., Ergen A., Yuksel S., Ozen H.
EUROPEAN UROLOGY SUPPLEMENTS , cilt.6, sa.2, ss.76, 2007 (SCI-Expanded) identifier

10. A cadaveric histological investigation of the prostate with three-dimensional reconstruction for better results in continence and erectile function after radical prostatectomy

Ozdemir M. B., Eskicorapci S. Y., Baydar D. E., Cumhur M., Onderoglu S., Ozen H.
PROSTATE CANCER AND PROSTATIC DISEASES , cilt.10, sa.1, ss.77-81, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

11. Percutaneous nephrolithotomy in children: Two centers experience with 167 renal units

ŞAHİN A., Bilen C. Y., Inci K., Tan B., Eren M., Elhaj S., et al.
EUROPEAN UROLOGY SUPPLEMENTS , cilt.6, sa.2, ss.243, 2007 (SCI-Expanded) identifier

12. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: A prospective, randomized clinical trial

Divrik R., Yildirim U., Zorlu F., Ozen H.
JOURNAL OF UROLOGY , cilt.175, sa.5, ss.1641-1644, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

13. Serum ribonuclease activity in the diagnosis of prostate cancer in men with serum prostate-specific antigen levels between 2.5 and 20 ng/mL

ESKICORAPCI S., Ozkara H. A., ONDER E., AKDOGAN B., ERKAN İ., CILIV G., et al.
CLINICAL BIOCHEMISTRY , cilt.39, sa.4, ss.363-366, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

14. Low-grade Ta (noninvasive) urothelial carcinoma of the bladder

Oosterlinck W., Solsona E., Akaza H., Busch C., Goebell P., Malmstrom P., et al.
UROLOGY , cilt.66, ss.75-89, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

15. Bilateral scrotal extra peritoneal herniation of ureters - Computed tomography urographic findings and review of the literature

Akpinar E., Turkbey B., Ozcan O., Akdogan B., KARÇAALTINCABA M., Ozen H.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY , cilt.29, sa.6, ss.790-792, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

16. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection

Eskicorapci S., Guliyev F., Akdogan B., Dogan H., Ergen A., Ozen H.
JOURNAL OF UROLOGY , cilt.173, sa.5, ss.1536-1540, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

17. Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: Results of a prospective multicenter study

Sozen S., Eskicorapci S., Kupelia B., Irkilata L., Altinel M., Ozer G., et al.
EUROPEAN UROLOGY , cilt.47, sa.3, ss.302-307, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

18. Proliferating-cell nuclear antigen (PCNA) as an Independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67

Taftachi R., Ayhan A., Ekici S., Ergen A., Ozen H.
BJU INTERNATIONAL , cilt.95, sa.4, ss.650-654, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

19. Can we obtain better specimens with an end-cutting prostatic biopsy device?

Dogan H., Eskicorapci S., Ertoy-Baydar D., Akdogan B., Gunay L., Ozen H.
EUROPEAN UROLOGY , cilt.47, sa.3, ss.297-301, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

20. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population

Aktas D., Hascicek M., Sozen S., Ozen H., Tuncbilek E.
CANCER GENETICS AND CYTOGENETICS , cilt.154, sa.1, ss.81-85, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

21. Successful management of chromophobe type renal cell carcinoma in pregnancy

Guven S., Guven E., Islamoglu E., Gunalp G., Ozen H.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY , cilt.44, sa.4, ss.362-363, 2004 (SCI-Expanded, Scopus) identifier identifier identifier

22. Resection of pulmonary metastases following chemotherapy for high stage testicular tumors

Eskicorapci S., Ekici S., Atsu M., Dogan R., Ozen H.
International Journal of Urology , cilt.11, sa.8, ss.634-639, 2004 (SCI-Expanded, Scopus) identifier identifier identifier

23. An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer

Eskicorapci S., Baydar D., AKBAL C., Sofikerim M., Gunay M., Ekici S., et al.
EUROPEAN UROLOGY , cilt.45, sa.4, ss.444-448, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

24. Urinary markers for urothelial cancer

Sozen S., Eskicorabci S., Ozen H.
BJU INTERNATIONAL , cilt.92, sa.6, ss.531-533, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

25. The role of the pathologist in the evaluation of radical prostatectomy specimens

Ekici S., Ayhan A., Erkan I., Bakkaloglu M., Ozen H.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY , cilt.37, sa.5, ss.387-391, 2003 (SCI-Expanded, Scopus) identifier identifier identifier

26. Prevalence of lower urinary tract symptoms in a community-based survey of men in Turkey

AKI F. T., Aygun C., Bilir N., Erkan I., Ozen H.
INTERNATIONAL JOURNAL OF UROLOGY , cilt.10, sa.7, ss.364-370, 2003 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

27. A novel surveillance protocol for stage I nonseminomatous germ cell testicular tumours

Atsu N., Eskicorapci S., ÜNER A., Ekici S., Gungen Y., Erkan I., et al.
BJU INTERNATIONAL , cilt.92, sa.1, ss.32-35, 2003 (SCI-Expanded, Scopus) identifier identifier identifier

28. The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin

Bilen C., Inci K., Erkan I., Ozen H.
JOURNAL OF UROLOGY , cilt.169, sa.5, ss.1702-1705, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

29. Gynecomastia following chemotherapy for testicular cancer

Uygur M., Ozen H.
UROLOGIA INTERNATIONALIS , cilt.70, sa.3, ss.253-254, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

30. Determination of prognosis in patients with prostate cancer treated with radical prostatectomy: Prognostic value of CD44v6 score

Ekici S., Ayhan A., Kendi S., Ozen H.
JOURNAL OF UROLOGY , cilt.167, sa.5, ss.2037-2041, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

31. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus

Kaplan S., Ekici S., Dogan R., Demircin M., Ozen H., Pasaoglu I.
American Journal of Surgery , cilt.183, sa.3, ss.292-299, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier identifier

32. False-positive results of the NMP22 test due to hematuria

Atsu N., Ekici S., Oge O., Ergen A., Hascelik G., Ozen H.
JOURNAL OF UROLOGY , cilt.167, sa.2, ss.555-558, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

33. Microstaging of pT1 transitional cell carcinoma of the bladder - Does it really differentiate two populations with different prognoses? (pT1 subcategory)

Sozen S., AKBAL C., Sokmensuer C., Ekici S., Ozen H.
UROLOGIA INTERNATIONALIS , cilt.69, sa.3, ss.200-206, 2002 (SCI-Expanded, Scopus) identifier identifier identifier

34. Comparison of BTA stat and NMP22 tests in the detection of bladder cancer

Oge O., Atsu N., Sahin A., Ozen H.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY , cilt.34, sa.6, ss.349-351, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

35. Is scrotal violation per se a risk factor for local relapse and metastases in stage I nonseminomatous testicular cancer?

Aki F., Bilen C., Tekin M., Ozen H.
UROLOGY , cilt.56, sa.3, ss.459-462, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

36. A study of the etiology of idiopathic calcium urolithiasis in children: Hypocitruria is the most important risk factor

Tekin A., Tekgul S., Atsu N., Sahin A., Ozen H., Bakkaloglu M.
JOURNAL OF UROLOGY , cilt.164, sa.1, ss.162-165, 2000 (SCI-Expanded, Scopus) identifier

37. Bladder cancer

Ozen H., Hall M.
CURRENT OPINION IN ONCOLOGY , cilt.12, sa.3, ss.255-259, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

38. Bilateral germ cell cancer of the testis: a report of 11 patients with a long-term follow-up

Tekin A., Aygun Y., Aki F., Ozen H.
BJU INTERNATIONAL , cilt.85, sa.7, ss.864-868, 2000 (SCI-Expanded, Scopus) identifier

39. Induction of mycobacteremia by intravesical bacillus Calmette-Guerin instillation in an experimental animal model and detection with polymerase chain reaction

Aygun C., Ozen H., Kocagoz T., Saribas Z., Aki T., Tekin I.
JOURNAL OF UROLOGY , cilt.163, sa.5, ss.1588-1590, 2000 (SCI-Expanded, Scopus) identifier

40. Proposal for changes in cystoscopic follow-up of patients with low-grade pTa gladder tumor

Oge O., Erdem E., Atsu N., Sahin A., Ozen H.
EUROPEAN UROLOGY , cilt.37, sa.3, ss.271-273, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

41. Marsupialization for bilateral pararenal lymphatic cysts

Ekici S., Ziraman I., Ozen H., Erkan I.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY , cilt.34, sa.1, ss.77-78, 2000 (SCI-Expanded) identifier

42. RETRIEVAL OF BROKEN DOUBLE-J CATHETER BY DORMIA BASKET

ERKAN I., SARIYUCE O., OZEN H.
BRITISH JOURNAL OF UROLOGY , cilt.66, sa.1, ss.107-108, 1990 (SCI-Expanded) identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 11

1. Studies with some mycobacterial culture filtrates for immunotherapeutical activity

ERTÜRK Z., BÜBER E., ÖZEN A. H., ÇELİKBIÇAK Ö., SALİH B., AÇAN N. L.
22th ISE International ConferenceAll Aspects of Laboratory Medicine, 30 Haziran - 03 Temmuz 2018, (Özet Bildiri)

2. PROSTAT KANSERİNİN DEFİNİTİF TEDAVİSİ SONRASI REKÜRRENSİNDE GA-68-PSMA PET/BT POZİTİFLİK ORANI VE ETKİ EDEN FAKTÖRLER

AYDIN A. M., HABERAL H. B., Artykov M., AKDOĞAN B., GÜDELOĞLU A., BİLEN C. Y., et al.
13. Üroonkoloji Kongresi, Türkiye, 8 - 12 Kasım 2017

3. GA-68 PSMA PET/BT’xxNİN PROSTAT KANSERİ LENF NODU EVRELEMESİNDEKİ ETKİNLİĞİ: ERKEN DÖNEM SONUÇLAR

AYDIN A. M., HABERAL H. B., Artykov M., AKDOĞAN B., GÜDELOĞLU A., BİLEN C. Y., et al.
13. Üroonkoloji Kongresi, Türkiye, 8 - 12 Kasım 2017 Sürdürülebilir Kalkınma

4. Designing and Performance of Antibacterial Polymeric Brushed Ureteral Stents In-vivo

GULTEKINOGLU M., KART D., KÜRÜM B., AKSOY E. A., KARAHAN S., SAĞIROĞLU M., et al.
International Biomedical Science and Technology Symposium, Ankara, Türkiye, 12 - 14 Mayıs 2017, (Tam Metin Bildiri)

5. Metastatik kastrasyona dirençli prostat kanser hastalarında kabazitakselin güvenlik verileri: Kabazitaksel Türkiye insani amaçlı ilaca erişim programı sonuçları

BAVBEK S., BAŞARAN M., ÖZEN A. H., ERMAN M., ÖZDOĞAN M., ÖZGÜROĞLU M., et al.
22. ULUSAL KANSER KONGRESİ, Türkiye, 19 - 23 Nisan 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

6. TOLERABILITY OF CABAZITAXEL IN SENIOR ADULTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) IN EUROPE

Heidenreich A., Bracarda S., Mason M., Ozen H., Sengelov L., Gerritsen W., et al.
37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Avusturya, 28 Eylül - 02 Ekim 2012, cilt.23, ss.307, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

7. EFFICACY AND TOLERABILITY OF TAXANE-BASED CHEMOTHERAPY IN SENIOR ADULTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC): A PROSPECTIVE INTERNATIONAL REGISTRY

Droz J., Efstathiou E., Heidenreich A., Yildirim A., Cabrera P., Kim C., et al.
37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Avusturya, 28 Eylül - 02 Ekim 2012, cilt.23, ss.308, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

8. Incidence of EDNRB hypermethylation in prostatic adenocarcinoma

Baydar D. E., Himmetoglu C., Ozen H., De Marzo A. M.
97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Colorado, Amerika Birleşik Devletleri, 1 - 07 Mart 2008, cilt.21, (Özet Bildiri) identifier

9. Lymphovascular invasion in prostatic adenocarcinoma

Ertoy-Baydar D., Baseskioglu B., Ozen H., Geyik P.
96th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, California, Amerika Birleşik Devletleri, 24 - 30 Mart 2007, cilt.20, (Özet Bildiri) identifier

10. Immunohistochemical analysis of PTEN expression in radical prostatectomies

Ertoy-Baydar D., Ozen H., Saracbasi O., De Marzo A. M.
96th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, California, Amerika Birleşik Devletleri, 24 - 30 Mart 2007, cilt.87, (Özet Bildiri) identifier

11. Telomere shortening correlates with short relapse-free survival time in prostate adenocarcinoma

Ertoy-Baydar D., Ozen H., Gurel B., Saracbasi O., Geyik P., De Marzo A. M.
96th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, California, Amerika Birleşik Devletleri, 24 - 30 Mart 2007, cilt.20, (Özet Bildiri) identifier
Metrikler

Yayın

54

Yayın (WoS)

48

Yayın (Scopus)

35

Atıf (WoS)

1017

H-İndeks (WoS)

19

Atıf (Scopus)

136

H-İndeks (Scopus)

4

Proje

2

Fikri Mülkiyet

3

Açık Erişim

2
BM Sürdürülebilir Kalkınma Amaçları